Cross-talk in cell death signaling - PubMed (original) (raw)

Review

. 2000 Oct 16;192(8):F21-5.

Affiliations

Review

Cross-talk in cell death signaling

S Roy et al. J Exp Med. 2000.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

Extrinsic and intrinsic cell death signaling pathways. The majority of proteolytic cleavage events that manifest the apoptotic phenotype are mediated by ‘effector’ caspases, such as caspase-3 and caspase-7, which become fully activated when the large and small subunits that are harbored within the dormant proenzyme are liberated after endoproteolysis by upstream ‘initiator’ caspases, such as caspase-8 and caspase-9. The initiator caspases themselves are activated by autoproteolytic activation after facilitated oligomerization. In the extrinsic pathway, this occurs as a consequence of ligand binding to ‘death receptor’ complexes, which leads to the recruitment of procaspase-8 via the adapter molecule FADD/Mort1. This pathway is modulated by the availability of the molecular components (putative type I and type II cells differ in this regard) and dominant-negative regulators such as decoy receptors and cFLIP/usurpin. For the majority of cell death stimuli, the intrinsic death signal is communicated through the mitochondrion by an unknown mechanism, which leads to several changes in the organelle, including the release of polypeptidic agents dangereux, such as cytochrome c and second mitochondria-derived activator of caspases (SMAC)/Diablo. This pathway is highly dependent on the stoichiometry of anti- versus proapoptotic Bcl-2 family members. When enabled, caspase-9 activation occurs at the hands of the oligomerization mediator APAF-1, which requires cytochrome c for the appropriate conformation. SMAC/Diablo helps to cross another apoptosis checkpoint by sequestering inhibitors of apoptosis protein (IAPs), which would otherwise block the actions of downstream effector caspases even in the presence of proteolytic maturation. Controversy surrounds the degree to which cross-talk occurs between the extrinsic and intrinsic pathways in vivo. At a molecular level, this appears to occur via the proteolysis of BID, which normally serves an antiapoptotic role within the intrinsic pathway until it is truncated (to tBID) by caspase-8 (derived from the extrinsic pathway), whereupon it promotes activation of the intrinsic pathway. In principle, signals from the extrinsic pathway may require the assistance of the intrinsic pathway, for example, when the signal strength is weak or when the IAP barrier is high and the actions of SMAC/Diablo become necessary.

Figure 2

Figure 2

How apoptotic thresholding might influence experimental outcome. Many possible explanations may account for the differential sensitivity of cells from the ‘Northern hemisphere’ labs (e.g., Krammer/Peter) versus those from the ‘Southern hemisphere’ (e.g., Strasser) to CD95 stimulation (the Krammer/Peter labs are located in Germany and the Strasser lab is in Australia, hence the Northern and Southern hemisphere references.). Herein is illustrated one hypothesis. It assumes that most cell types have an apoptotic threshold that, when breached, results in apoptotic cell death. This apoptotic threshold (represented by the red plane) requires, say, 10 arbitrary apoptotic units (which could be, among other things, a critical mass of caspase catalytic activity). The ability of a cell to cross this threshold depends on the combined contributions of the extrinsic cell death pathway (gray) and the fraction of the intrinsic pathway (blue) that can be engaged through pathway cross-talk. Type I cells (first bar), in both the Northern and Southern hemispheres, harbor a very efficient DISC mechanism that alone can contribute the necessary apoptotic units to breach the threshold. Thus, regardless of the status of the intrinsic pathway, and even if it is completely blocked by the presence of Bcl-2, the type I cell can muster the necessary currency to engage the apoptotic machinery and die. Therefore, extrinsic and intrinsic pathways in type I cells appear independent (assuming intrinsic does not talk to extrinsic). In type II cells, DISC formation is weaker and the extrinsic pathway depends more on contributions from the intrinsic pathway. These cells behave differently in the Northern hemisphere versus the Southern hemisphere. In the Northern hemisphere, the combination of the extrinsic contribution and the fraction of the intrinsic pathway that it is able to engage is sufficient for apoptosis to proceed (second bar). Attenuation of the intrinsic component, by Bcl-2 overexpression for example, reduces the total number of apoptotic units to below the apoptotic threshold and the cells survive. The extrinsic pathway, therefore, appears to be modulated by Bcl-2. In the Southern hemisphere, the number of available apoptotic units that can be contributed by the intrinsic pathway may be lower. Thus, engagement of the extrinsic pathway with ligating CD95 (Fas/Apo1) antibody or trimerized ligand is not sufficient to mediate passage across the apoptotic threshold on its own (third bar). With a more efficient stimulus, mediated by multimerized CD95L, for example (fourth bar), a critical mass of the extrinsic pathway is enlisted to breach the apoptotic threshold, regardless of the contribution from the intrinsic pathway. Cell death in this scenario is therefore insensitive to Bcl-2 overexpression. The differences observed in the Northern and Southern hemispheres might therefore be explained by a combination of (a) the number of apoptotic units within the intrinsic pathway that can be recruited by cross-talk from the extrinsic pathway (lower in the South) and (b) the strength of the apoptotic stimulus (ligating antibodies and trimerized CD95L being equivalent but weaker than multimerized CD95L).

Comment on

Similar articles

Cited by

References

    1. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999;15:269–290. - PubMed
    1. Green D.R. Apoptotic pathwayspaper wraps stone blunts scissors. Cell. 2000;102:1–4. - PubMed
    1. Siegel R.M., Frederiksen J.K., Zacharias D.A., Chan F.K., Johnson M., Lynch D., Tsien R.Y., Lenardo M.J. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 2000;288:2354–2357. - PubMed
    1. Chan F.K., Chun H.J., Zheng L., Siegel R.M., Bui K.L., Lenardo M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science. 2000;288:2351–2354. - PubMed
    1. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO (Eur. Mol. Biol. Organ.) J. 1998;17:1675–1687. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources